Jess S. Morgan & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Jess S. Morgan & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$4.01M	Buy	50,523 +477	+1%	+$40.2K	3.49%	10
2022 Q2	$3.72M	Buy	50,046 +4,773	+11%	+$358K	3.85%	9
2022 Q1	$4.07M	Buy	45,273 +6,582	+17%	+$608K	2.96%	15
2021 Q4	$4.33M	Buy	38,691 +2,659	+7%	+$321K	2.66%	21
2021 Q3	$4.53M	Buy	36,032 +3,680	+11%	+$474K	2.99%	14
2021 Q2	$4.38M	Buy	32,352 +4,392	+16%	+$577K	2.88%	14
2021 Q1	$3.79M	Sell	27,960 -471	-2%	-$70.5K	2.66%	18
2020 Q4	$4M	Buy	28,431 +828	+3%	+$106K	3.19%	8
2020 Q3	$3.08M	Sell	27,603 -1,113	-4%	-$125K	3.07%	11
2020 Q2	$3.21M	Sell	28,716 -7,139	-20%	-$703K	3.49%	6
2020 Q1	$2.78M	Buy	35,855 +3,926	+12%	+$348K	3.61%	8
2019 Q4	$3.04M	Buy	+31,929	New	+$2.76M	2.98%	11

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Jess S. Morgan & Co's XBI Position: Q3 2022 in Review

Jess S. Morgan & Co increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.95% in Q3 2022, buying an estimated $40.2K and bringing the position to 50,523 shares worth $4.01M. The position accounts for 3.49% of the portfolio, ranked #10.

Jess S. Morgan & Co first reported a position in XBI in Q4 2019 and has held it in 12 quarters since. The position peaked at $4.53M in Q3 2021. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Jess S. Morgan & Co held 50,523 shares of State Street SPDR S&P Biotech ETF worth $4.01M as of Q3 2022.
Jess S. Morgan & Co bought 477 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $40.2K.
State Street SPDR S&P Biotech ETF made up 3.49% of Jess S. Morgan & Co's portfolio in Q3 2022, its #10 holding.
Jess S. Morgan & Co first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 12 quarters since.
Jess S. Morgan & Co's State Street SPDR S&P Biotech ETF position peaked at $4.53M in Q3 2021.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Jess S. Morgan & Co's 13F filing for Q3 2022, filed 21 Oct 2022.